Related Experiment Video
Updated: Aug 6, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Parallels between arterial and cartilage calcification: what understanding artery calcification can teach us about
Frank Rutsch1, Robert Terkeltaub
1Veterans Affairs Medical Center, University of California, San Diego School of Medicine, San Diego, California 92161, USA.
Insights
Arterial and cartilage calcification share common pathways, often linked to aging, inflammation, and genetic factors affecting calcification inhibitors. Understanding these links may lead to new treatments for chondrocalcinosis.
Area of Science:
- Biochemistry
- Pathology
- Genetics
Background:
- Arterial calcification and chondrocalcinosis are degenerative processes linked to aging and chronic inflammation.
- Both conditions involve altered gene expression and release of mineralization-competent cell fragments.
- Genetic disorders can cause both artery and cartilage calcification, impacting bone formation.
Purpose of the Study:
- To review recent findings on the pathogenesis of arterial calcification and chondrocalcinosis.
- To highlight shared mechanisms and genetic factors involved in both calcification processes.
- To explore potential therapeutic implications for chondrocalcinosis based on arterial calcification research.
Main Methods:
- Literature review of recent research on arterial calcification and chondrocalcinosis.
- Analysis of genetic and molecular mechanisms underlying pathological calcification.
- Discussion of the role of calcification inhibitors and inflammatory processes.
Main Results:
- Pathologic arterial and articular cartilage calcification share common underlying mechanisms.
- Deficiencies in calcification inhibitors like PC-1/nucleotide pyrophosphatase phosphodiesterase 1 contribute to both conditions.
- Inflammatory cytokines and disordered mineral homeostasis also drive these calcification processes.
Conclusions:
- Recent advances in understanding arterial calcification offer insights into chondrocalcinosis pathogenesis.
- Targeting calcification inhibitors and inflammatory pathways may provide therapeutic strategies.
- Further research into shared mechanisms can advance treatments for degenerative calcification diseases.
Abstract:
The pathogenesis of arterial calcification and chondrocalcinosis has become concurrently illuminated in recent years. For example, both processes occur in chronic inflammation-mediated degenerative diseases associated with aging (including atherosclerosis and osteoarthritis). Both processes are also modulated by altered gene expression by resident cells and by the release of mineralization-competent cell fragments (matrix vesicles and apoptotic bodies). Among the variety of genetic diseases associated with artery calcification are disorders that also promote cartilage calcification and/or dysregulated bone formation. Our discussion highlights that pathologic arterial and articular cartilage calcification both can be owing to genetic deficiencies of calcification inhibitors such as the inorganic pyrophosphate-generating ectoenzyme PC-1/nucleotide pyrophosphatase phosphodiesterase 1. Conversely, pathologic arterial and articular cartilage calcification also can primarily arise as a consequence of active processes driven by inflammatory cytokines and by disordered calcium and inorganic phosphate homeostasis. As discussed in this review, recent developments in the pathogenesis of arterial calcification provide valuable information pertinent to potential future advances in controlling chondrocalcinosis.
Related Concept Videos
Growth of Cartilage and Bone Tissue
Bone Formation by Endochondral Ossification
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease I: Introduction

